Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04460456
Brief Title: A Study of SBT6050 Alone and in Combination With Pembrolizumab in Patients With Advanced HER2 Expressing Solid Tumors

First Submitted : June 29, 2020
First Submitted that Met QC Criteria : July 6, 2020
First Posted : July 7, 2020

Last Update Submitted that Met QC Criteria : April 28, 2021
Last Update Posted : May 3, 2021